Newsletter Subject

This stock has a catalyst event coming soon

From

ragingbull.com

Email Address

support@ragingbull.com

Sent On

Mon, Oct 10, 2022 04:47 PM

Email Preheader Text

is quietly building a lot of strength in what can only be described as a “weak market”. Ev

[image] Sponsored by: [image]() [MYMD](=) is quietly building a lot of strength in what can only be described as a “weak market”. Even Yahoo Finance has it rated as a short-term “bullish” right now: [image] What I really want to see is the stock hold above the $3 level for at least a couple of days. If it can do that, then I think this has a decent shot of testing the 200-day moving average near $3.70. Personally, I think there is much more potential than that. Just look at the potential benefits of its leading drug candidate, MYMD-1®, especially in regard to current TNF-alpha inhibitors on the market – it’s NO SURPRISE why! TNF inhibitors have been the leading drugs by revenue for years, only falling to Pfizer’s Covid vaccine in the last couple of years. For example, Humira is expected to be SECOND in projected sales of over $20B in 2022. What most people don’t know is that all of these top-prescribed TNF inhibitors are in LARGE molecule form, which means they are UNABLE to cross the blood brain barrier – this barrier prevents harmful substances from entering the brain. However, it also keeps out beneficial medications that can treat brain-related disorders, including multiple sclerosis (MS) as well as depression in age or inflammatory-related diseases. This is where MYMD-1® differs – as it is in SMALL molecule form it is being designed to cross the blood brain barrier – opening up all kinds of possibilities in treating brain-related disorders, including potentially MS! [image] Currently, MYMD-1® is in Phase 2 trials for sarcopenia (aging) but the company has near term plans to advance MYMD-1® into a phase 2 clinical trial for rheumatoid arthritis. So keep your eye on this company as it has ambitious plans to tackle some of the biggest health challenges facing our population today! To Your Success! ISSUER-PAID ADVERTISEMENT: MyMD, Inc. (“MYMD” or the “Company”) HAS PAID OR WILL PAY SHERWOOD VENTURES, LLC (“Sherwood”) TWENTY-THOUSAND DOLLARS USD PER MONTH FOR THREE MONTHS (THE “INITIAL TERM”) IN CASH, SHARES OF RESTRICTED COMMON STOCK WITH A VALUE OF ONE-HUNDRED-FIFTY THOUSAND DOLLARS, AND WARRANTS VALUED AT ISSUANCE OF SEVENTY-FIVE THOUSAND DOLLARS FOR MARKETING SERVICES INCLUDING COMMUNICATING TO THE PUBLIC ABOUT THE COMPANY THROUGH SHERWOOD’S AFFILIATE RAGINGBULL.COM, LLC (“RAGING BULL”), AMONG OTHERS. THIS ADVERTISEMENT IS PART OF THOSE ISSUER-PAID MARKETING SERVICES. FOR DETAILED COMPENSATION AND MORE INFORMATION, PLEASE SEE THE FULL DISCLOSURE LOCATED AT HTTPS://BOARDROOMINVESTING.COM/MYMD-DISCLAIMER [( DISCLAIMER: To more fully understand any Ragingbull.com, LLC (“RagingBull”) subscription, website, application or other service (“Services”), please review our full disclaimer located at [(=) FOR EDUCATIONAL AND INFORMATION PURPOSES ONLY; NOT INVESTMENT ADVICE. Any RagingBull Service offered is for educational and informational purposes only and should NOT be construed as a securities-related offer or solicitation, or be relied upon as personalized investment advice. RagingBull strongly recommends you consult a licensed or registered professional before making any investment decision. RESULTS PRESENTED NOT TYPICAL OR VERIFIED.RagingBull Services may contain information regarding the historical trading performance of RagingBull owners or employees, and/or testimonials of non-employees depicting profitability that are believed to be true based on the representations of the persons voluntarily providing the testimonial.However, subscribers’ trading results have NOT been tracked or verified and past performance is not necessarily indicative of future results, and the results presented in this communication are NOT TYPICAL. Actual results will vary widely given a variety of factors such as experience, skill, risk mitigation practices, market dynamics and the amount of capital deployed. Investing in securities is speculative and carries a high degree of risk; you may lose some, all, or possibly more than your original investment. RAGINGBULL IS NOT AN INVESTMENT ADVISOR OR REGISTERED BROKER. RagingBull nor any of its owners or employees is registered as a securities broker-dealer, broker, investment advisor (IA), or IA representative with the U.S. Securities and Exchange Commission, any state securities regulatory authority, or any self-regulatory organization. Employees, owners, and other service providers of [Ragingbull.com](=), LLC are paid in whole or in part by commission based on their sales of Services to subscribers. WE MAY HOLD SECURITIES DISCUSSED. RagingBull has not been paid directly or indirectly by the issuer of any security mentioned in the Services. However, [Ragingbull.com](), LLC, its owners, and its employees may purchase, sell, or hold long or short positions in securities of the companies mentioned in this communication. If you have a current active subscription with RagingBull you will need to contact us [here](=) if you want to cancel your subscription. Opting out of emails does not remove you from your service at RagingBull. [Unsubscribe]( RagingBull.com, LLC 62 Calef Hwy #233 Lee, New Hampshire 03861 United States (800) 380-7072

Marketing emails from ragingbull.com

View More
Sent On

04/12/2024

Sent On

03/12/2024

Sent On

03/12/2024

Sent On

29/11/2024

Sent On

27/11/2024

Sent On

26/11/2024

Email Content Statistics

Subscribe Now

Subject Line Length

Data shows that subject lines with 6 to 10 words generated 21 percent higher open rate.

Subscribe Now

Average in this category

Subscribe Now

Number of Words

The more words in the content, the more time the user will need to spend reading. Get straight to the point with catchy short phrases and interesting photos and graphics.

Subscribe Now

Average in this category

Subscribe Now

Number of Images

More images or large images might cause the email to load slower. Aim for a balance of words and images.

Subscribe Now

Average in this category

Subscribe Now

Time to Read

Longer reading time requires more attention and patience from users. Aim for short phrases and catchy keywords.

Subscribe Now

Average in this category

Subscribe Now

Predicted open rate

Subscribe Now

Spam Score

Spam score is determined by a large number of checks performed on the content of the email. For the best delivery results, it is advised to lower your spam score as much as possible.

Subscribe Now

Flesch reading score

Flesch reading score measures how complex a text is. The lower the score, the more difficult the text is to read. The Flesch readability score uses the average length of your sentences (measured by the number of words) and the average number of syllables per word in an equation to calculate the reading ease. Text with a very high Flesch reading ease score (about 100) is straightforward and easy to read, with short sentences and no words of more than two syllables. Usually, a reading ease score of 60-70 is considered acceptable/normal for web copy.

Subscribe Now

Technologies

What powers this email? Every email we receive is parsed to determine the sending ESP and any additional email technologies used.

Subscribe Now

Email Size (not include images)

Font Used

No. Font Name
Subscribe Now

Copyright © 2019–2025 SimilarMail.